Coloplast A/S (OTCMKTS:CLPBF) Stock Price Down 1.4% – Should You Sell?

Coloplast A/S (OTCMKTS:CLPBF – Get Free Report)’s stock price fell 1.4% during mid-day trading on Tuesday. The stock traded as low as $74.32 and last traded at $74.32. 33 shares were traded during mid-day trading, a decline of 99% from the average session volume of 2,916 shares. The stock had previously closed at $75.40.

Coloplast A/S Stock Down 1.4%

The business has a 50 day simple moving average of $67.48 and a 200-day simple moving average of $66.57.

Coloplast A/S Company Profile

(Get Free Report)

Coloplast A/S is a Denmark-based medical technology company that develops and markets products and services for people with intimate health care needs. Its main business areas include ostomy care, continence care, wound and skin care, and interventional urology. The company’s product portfolio includes ostomy bags and accessories, intermittent catheters, bowel management systems, urological implants, and advanced wound dressings. Coloplast markets products under brands such as SenSura, SpeediCath, Peristeen, Titan and Biatain, serving patients and health care professionals through hospitals, clinics and home-care channels.

Further Reading

Receive News & Ratings for Coloplast A/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Coloplast A/S and related companies with MarketBeat.com's FREE daily email newsletter.